Video

Keeping the Dream Alive: Supporting Female Survivors

Author(s):

Barbara Bittner, RN, OCN

Barbara Bittner, RN, OCN, a finalist for the CURE® Extraordinary Healer® Award for Oncology Nursing, talked about her advocacy work with Charlene’s Dream – a community-based cancer resource center for women.

Barbara Bittner, RN, OCN, a finalist for the CURE® Extraordinary Healer® Award for Oncology Nursing and a nurse oncology navigator at AdventHealth, talked about her advocacy work with Charlene’s Dream — a community-based cancer resource center that provides information and support to help patients cope with their disease effectively.

Not only does the boutique provide educational resources, but also monthly support groups, mastectomy bras, breast prosthesis and wigs for survivors.

Bittner, a co-founder of Charlene’s Dream who ran the art therapy group, also discussed the story behind the “warm and welcoming haven for those with cancer.” The free services are available, as Bittner pointed out, to any woman with any type of cancer — not just breast cancer.

Related Videos
Image of woman.
Dr. Andreas M. Kaiser is a professor and chief of the Division of Colorectal Surgery in the Department of Surgery at City of Hope comprehensive cancer center in Duarte, California.
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.
Image of woman with blonde hair.
Dr. Frederick L. Locke sat down with CURE® to discuss treatment with cema-cel in the ALPHA/ALPHA2 studies for relapsed/refractory large B-cell lymphoma.
Dr. Park sat down for an interview with CURE® to discuss the key takeaways from the 2025 Annual ASCO Genitourinary Cancers Symposium.
Treatment with cemacabtagene ansegedleucel demonstrated responses in patients with relapsed or treatment-resistant large B-cell lymphoma.
There was no evidence that CAR T directly caused secondary malignancies, despite FDA warnings, citing prior treatments as the cause, according to research.
a man and a woman in front of a dark blue background
a man and a woman in front of a dark blue background
Related Content
green background with white text indicating FDA Approval, What You Need to Know
March 8th 2025

FDA Approves Biosimilars for Cancer-Related Skeletal Events

Alex Biese
The FDA has approved Stoboclo and Osenvelt to address skeletal issues faced by patients with cancer.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer
March 6th 2025

Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer

Ryan Scott
Artificial intelligence aids in polyp detection, enhancing colonoscopy effectiveness and reducing the risk of colorectal cancer progression in patients.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
Image of woman holding pink ribbon.
March 4th 2025

Verzenio Combo May Improve Survival in HR+/HER2– Advanced Breast Cancer

Spencer Feldman
Verzenio plus Faslodex improved progression-free survival in HR+/HER2– advanced breast cancer after CDK/6i failure, with a manageable safety profile.
Illustration of woman with brown hair.
March 4th 2025

Breast Cancer And Depending On The Kindness Of Strangers

Laura Yeager
I reflect on my unexpected bond with a neighbor during my breast cancer treatment, finding comfort in his company when I needed someone to talk to.